Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma.

Abstract

The FND combination is highly active in patients with recurrent or relapsed indolent lymphoma and results in a high percentage of CRs. Because of the risk of opportunistic infections, we currently recommend prophylaxis with TMP-SMX and advise deletion of corticosteroids for patients who develop opportunistic infections.